2022 Patient Impact Awards
In 2022, we are honoring our 2022 awardees at events within their own communities.
In 2022, Cures Within Reach will present David Fajgenbaum, MD, MBA, MSc and Incyte with their 2022 Patient Impact Awards, recognizing each organization’s outstanding achievements in creating impact for patients by repurposing existing science and medicine.
Presenting the 2022 Patient Impact Research Award
David Fajgenbaum and Barbara Goodman at the CDCN Patient & Loved One Summit, Sep 2022
Barry Flannelly, Executive Vice President and General Manager, Incyte North America, accepting the 2022 Patient Impact Industry Award from Clare Thibodeaux, PhD
During 2022, Cures Within Reach will celebrate and honor:
- David Fajgenbaum’s tireless efforts not only to identify a repurposed treatment for his own rare disease, but also to study and advance this therapeutic option and others for other patients as Co-Founder of the Castleman Disease Collaborative Network and his continued efforts to encourage repurposing as well as his recent activities to find, grade and advance therapies for COVID-19.
- Incyte’s efforts in bringing ruxolitinib to patients with several different rare blood cancers and for complications following bone marrow transplant, treatments for atopic dermatitis and vitiligo, as well as supporting ongoing clinical trials using approved therapies for pediatric indications.
Read the entire press release here. To join us in celebrating these 2022 Awardees as a volunteer, through sponsorship or in other ways, please email admin@cureswithinreach.org.
Background: Awards are given to industry leaders, scientists, philanthropists and organizations driving improvements in clinical care through repurposing at events in 2022. These events celebrate our collective commitment to patient impact through repurposing.
Congratulations to our 2022 Patient Impact Awardees:
2022 Janet Davison Rowley Patient Impact Research Award
2022 Patient Impact Industry Award
Janet Davison Rowley Patient Impact Research Award
The Janet Davison Rowley Patient Impact Research Award is given to one or more researchers, clinicians or computational biologists who have created positive patient impact through repurposing research. We honor the impact Dr. Rowley (1925-2013) had on patients through her clinical care and medical research, including her pioneering work that led to the creation of drugs that were later repurposed for additional indications.
Previous Awardees Include:
- ReFRAME at Calibr, Scripps Research
- SPARK at Stanford, Stanford University School of Medicine
- Dr. Denise Faustman, Massachusetts General Hospital and Harvard Medical School
- Dr. Scott Weir, The University of Kansas Cancer Center and the University of Kansas Medical Center (See a short video about his research at the top of this page!)
- Dr. Berish Rubin & Dr. Sylvia Anderson, Fordham University
- Dr. Marty St. Clair, Viiv Healthcare
- Dr. Vincent Rajkumar, Mayo Clinic
- Dr. James Surmeier and Dr. Tanya Simuni, Northwestern University
- Dr. David Teachey, Children’s Hospital of Philadelphia
The researcher, clinician, and/or computational biologist should fit the following profile:
- Has successfully repurposed a drug, device or nutraceutical for human clinical use, which is either used off-label or has been approved by the FDA or other regulatory agency; has made significant advancements in repurposing research; and/or is a recognized thought leader in repurposing research
- Has published repurposing research data in the scientific literature
- Patients who use or used a repurposed treatment discovered and/or advanced by the nominee enjoy an increased quality and/or length of life
- Will work with Cures Within Reach on public recognition of the award
Golan Christie Taglia Patient Impact Philanthropy Award
The Golan Christie Taglia Patient Impact Philanthropy Award is given to an individual, group or organization that has created positive patient impact by advocating for patients or contributing to the growth of repurposing research through financial, operational or professional philanthropic support. Named in honor of Golan Christie Taglia LLP in gratitude for their many years of financial and in-kind support for Cures Within Reach, helping us to grow and thrive.
Previous Awardees Include:
- CURE ID at the FDA and NCATS/NIH
- Drugs for Neglected Diseases initiative
- The Alzheimer's Drug Discovery Foundation
- The Leukemia & Lymphoma Society
- FRAXA Research Foundation
- Dr. Nicolas Sireau, with Professor Lakshminarayan Ranganath, AKU Society
- The Robert Wood Johnson Foundation
- George and Judy Goldman, Goldman Philanthropic Partnerships
- Golan Christie Taglia LLP
The individual, group, or organization selected should fit the following profile:
- Be a recognized leader in an advocacy, research, healthcare, philanthropic or non-governmental (NGO) organization endeavor, or be a supporter of such an endeavor
- Has made significant philanthropic contributions and/or created fundraising that have resulted in the advancement of repurposing
- Has brought together various stakeholders to create an increased quality and/or length of life for patients
- Will work with Cures Within Reach on public recognition of the award
Patient Impact Industry Award
The Patient Impact Industry Award is given to an industry individual, group or organization that has created positive patient impact by contributing to the growth and profile of repurposing research within the healthcare industry, through financial, operational and/or collaborative support. Nominees may represent any size of industry organization, from start up to large pharmaceutical companies. In addition, nominees may also represent any sector that impacts repurposing research, including biotech, pharma and indutry service / support providers.
Previous Awardees Include:
- Eli Lilly and Company
- Camargo Pharmaceutical Services
- Jazz Pharmaceuticals
- Novartis
- Timothy P. Walbert, Horizon Therapeutics plc
- Dr. Jerome B. Zeldis, Sorrento Therapeutics, formerly of Celgene Global Health and Celgene Corporation
- Dr. Richard DiMarchi, University of Indiana, formerly of Eli Lilly
- Dr. Norbert Riedel, Aptinyx Inc., formerly of Baxter International
- Michael S. Rosen, Rosen Bioscience Strategies, formerly of Illinois Science + Technology Park and Forest City Realty Trust
The individual, group, or organization selected should fit the following profile:
- Is or was in a significant leadership position in the healthcare industry and has demonstrated a commitment to collaboration, service and/or support for repurposing research
- Focused the attention of the healthcare industry, and/or their own group or organization and similar groups or organizations, on improving the lives of patients through repurposing
- Patients who use or used a repurposed treatment supported by this nominee enjoy an increased quality and/or length of life
- Will work with Cures Within Reach on public recognition of the award
Questions? Contact Clare Thibodeaux, PhD, Vice President of Scientific Affairs: clare@cureswithinreach.org or 847-745-1250